WisPaper
WisPaper
Search
Assistant
Pricing
TrueCite

Is paracetamol safer than ibuprofen for long-term use?

Paracetamol is safer for long-term use than ibuprofen, which carries higher risks of kidney and gastrointestinal damage.

Direct answer

For long-term use, paracetamol is generally safer than ibuprofen, but neither is risk-free. Ibuprofen carries a higher risk of kidney damage and gastrointestinal bleeding with prolonged use, as shown in studies of preterm infants where ibuprofen caused significantly more renal failure and GI bleeding than paracetamol [3][4]. However, paracetamol has its own long-term concerns: prenatal exposure has been linked to possible increased risks of neurodevelopmental, atopic, and reproductive issues [9]. Across the studies here, the evidence consistently points to ibuprofen's greater risk of organ-specific harm with extended use, while paracetamol's risks are more subtle and less immediate.

9sources cited

This article was generated with WisPaper-powered search and paper analysis.

Why is paracetamol generally considered safer for long-term use?

The central difference is that ibuprofen, like all NSAIDs, can damage the kidneys and stomach lining when used regularly over time. Paracetamol does not cause these problems, but it can harm the liver if taken in high doses. For long-term use at recommended doses, paracetamol's safety profile is better because kidney and gastrointestinal damage are more common with ibuprofen. A meta-analysis of 18 trials in preterm infants found that ibuprofen caused significantly more gastrointestinal bleeding (risk ratio 0.32, meaning ibuprofen had about three times the risk) and renal failure (risk ratio 0.37, meaning about 2.7 times the risk) compared to paracetamol [3]. Another study using FDA adverse event data in infants confirmed that ibuprofen was associated with significantly more kidney and urinary disorders, while paracetamol was linked to more liver problems [4].

What do the studies agree on, and where do they conflict?

The studies consistently show that for short-term use, both drugs are similarly effective and safe for fever and pain in children and adults [1][2][6]. For example, a network meta-analysis of 31 trials in children found no difference in adverse events between ibuprofen and paracetamol when used for fever over six hours [2]. However, the picture changes with longer or more frequent use. Multiple studies in preterm infants, who require days of treatment for a heart condition called patent ductus arteriosus, all found that paracetamol was as effective as ibuprofen but with fewer kidney and gut side effects [3][5][8]. One pilot trial found no difference in efficacy or safety between the two drugs over a short course, but it was too small to detect rare harms [5]. The main conflict is about paracetamol's long-term safety: a systematic review of 30 studies found that prenatal exposure to paracetamol was associated with possible increased risks of neurodevelopmental, atopic, and reproductive problems, though the evidence was limited [9]. This means paracetamol is not entirely risk-free, but its risks are different and less immediate than ibuprofen's.

What does this mean for someone considering long-term use?

If you need to take a pain reliever or fever reducer regularly for more than a few days, paracetamol is the safer first choice, provided you do not exceed the maximum daily dose (typically 3,000-4,000 mg for adults, depending on your health). Ibuprofen should be reserved for short-term use (a few days at a time) because the risk of kidney damage and stomach bleeding increases with longer use. A study in dengue patients found that even low-dose ibuprofen was safe for short-term fever management, but it did not evaluate long-term use [7]. For chronic pain conditions, talk to your doctor about the lowest effective dose and duration. The evidence from preterm infants, who are especially vulnerable, clearly shows that ibuprofen's kidney and gut risks emerge with just a few days of treatment [3][8]. Paracetamol's liver risk is mainly from overdose, not from normal long-term use, but the possible long-term developmental concerns from prenatal exposure [9] highlight that no drug is completely benign.

About These Sources

This answer is built on 9 peer-reviewed studies — published from 2022 to 2026, 7 from 2024 or later, 2 in Q1 journals — selected as the most relevant from 10 studies that passed quality screening, drawn from 55 papers retrieved from a database of over 500 million.

Sources used in this answer

1

Effect of ibuprofen versus acetaminophen on postpartum hypertension: a systematic review and meta-analysis of randomized controlled trials.

A meta-analysis of 6 RCTs (535 patients) found that short-term postpartum ibuprofen did not increase blood pressure compared to acetaminophen in women with hypertensive disorders of pregnancy.

2

Short-term Dual Therapy or Mono Therapy With Acetaminophen and Ibuprofen for Fever: A Network Meta-Analysis

A network meta-analysis of 31 trials (5,009 children) found no difference in adverse events between ibuprofen and acetaminophen for fever in children over 6 hours.

3

Efficacy of acetaminophen compared to ibuprofen for patent ductus arteriosus in preterm neonates: A systematic review and meta-analysis

A meta-analysis of 18 RCTs (1,946 preterm infants) found ibuprofen caused significantly more gastrointestinal bleeding (RR 0.32) and renal failure (RR 0.37) than paracetamol, with similar efficacy for PDA closure.

4

Adverse Event Profiles of Acetaminophen and Ibuprofen in Infants: A Food and Drug Administration Adverse Event Reporting System Database Retrospective Cohort Study

An analysis of the FDA adverse event database in infants found ibuprofen was associated with more kidney/urinary disorders (OR 0.19) and paracetamol with more liver disorders (OR 2.61).

5

Paracetamol or ibuprofen? A pilot study comparing rescue therapy for PDA in preterm infants within the first month

A pilot RCT in 32 preterm infants found no significant difference in efficacy or safety between IV paracetamol and IV ibuprofen for PDA closure, but the study was too small to detect rare harms.

6

Comparing the Efficacy of Paracetamol, Ibuprofen, and a Combination of the Two Drugs in Relieving Pain and Fever in the Pediatric Age Group: A Prospective Observational Study

A prospective study of 108 children found that paracetamol and ibuprofen combination was more effective for fever and pain than either alone, with no significant biochemical derangements over 48 hours.

7

Safety of Low‐Dose Ibuprofen in Non‐Severe Dengue Patients for Managing Fever Is Consistent With Acetaminophen: A Retrospective Observational Study

A retrospective study of 262 dengue patients found that low-dose ibuprofen had similar safety to acetaminophen for short-term fever management, with no gastrointestinal bleeding within 3 months.

8

Evaluating The Therapeutic Efficacy And Safety Of Oral Ibuprofen Compared With IV Paracetamol In Preterm PDA

A comparative study in preterm infants found oral ibuprofen had 82% PDA closure rate vs 78% for IV paracetamol, but paracetamol had better renal safety and fewer gastrointestinal/hematologic side effects.

9

Long-Term Safety of Prenatal and Neonatal Exposure to Paracetamol: A Systematic Review

A systematic review of 30 studies found that prenatal paracetamol exposure was associated with possible increased risks of neurodevelopmental, atopic, and reproductive adverse outcomes, though evidence was limited.